Genes May Play Role in More Severe Form of PMS

Study adds to evidence of a biological cause of condition, researchers say

By Randy Dotinga

Tuesday, January 3, 2017

TUESDAY, Jan. 3, 2017 (HealthDay News) -- A new study links the activity of certain genes to a premenstrual mood disorder that affects 2 to 5 percent of women of reproductive age.

The disorder, known as premenstrual dysphoric disorder (PMDD), causes more severe symptoms than premenstrual syndrome, better known as PMS. PMDD symptoms include disabling irritability, sadness and anxiety before a menstrual period.

The link "adds to evidence that PMDD is a disorder of cellular response to estrogen and progesterone," said study researcher Dr. Peter Schmidt. He's with the National Institute of Mental Health, part of the U.S. National Institutes of Health.

"For the first time, we now have cellular evidence of abnormal signaling in cells derived from women with PMDD, and a plausible biological cause for their abnormal behavioral sensitivity to estrogen and progesterone," he said in an NIH news release.

Scientists had already known that women with the disorder are especially sensitive to changes in sex hormones, even though their hormone levels are normal.

For the new study, the researchers looked at how gene expression was controlled in white blood cells. They found a complex of genes that acts differently in women with the disorder compared to women without it.

Dr. David Goldman, of the U.S. National Institute on Alcohol Abuse and Alcoholism, worked with Schmidt on the study.

"This is a big moment for women's health, because it establishes that women with PMDD have an intrinsic difference in their molecular apparatus for response to sex hormones -- not just emotional behaviors they should be able to voluntarily control," Goldman said.

The study appears Jan. 3 in the journal Molecular Psychiatry.

SOURCE: U.S. National Institutes of Health, news release, Jan. 3, 2017

HealthDay

News stories are provided by HealthDay and do not reflect the views of MedlinePlus, the National Library of Medicine, the National Institutes of Health, the U.S. Department of Health and Human Services, or federal policy.